Table 3.
Women | ||||
---|---|---|---|---|
LUTS | FSD | UI | UTI | |
N total respondents | 579 | 371 | 571 | 555 |
N (%) | 128 (22) | 153 (41) | 172 (30) | 95 (17) |
Autonomic Neuropathy | 1.28 (0.85-1.92) | 1.67 (1.07-2.60) | 1.28 (0.88-1.85) | 1.57 (1.00-2.47) |
Men | ||||
LUTS | ED | LD | OD | |
N total respondents | 643 | 635 | 598 | 564 |
N(%) | 158 (25) | 290 (46) | 243 (41) | 83 (15) |
Autonomic Neuropathy | 2.07 (1.42-3.01) | 2.82 (2.01-3.94) | 1.28 (0.91-1.80) | 2.40 (1.49-3.88) |
Data from Wessels, H. et al., 2018, Diabetes Care
Note: Data are odds ratios (95% CI) unless otherwise specified. Significant values are in boldface type. Autonomic neuropathy defined at EDIC year 16/17 as an R-R variation <15 or R-R variation <20 in combination with a Valsalva ratio ≤1.5 or a decrease of >10 mmHg in diastolic blood pressure upon standing. DCCT/EDIC, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications; LUTS, lower Urinary tract symptoms; UI, urinary incontinence; UTI urinary tract infection; ED, erectile dysfunction; OD, orgasmic dysfunction; LD, low sexual desire; FSD, female sexual dysfunction